Inhibitory effects of fidarestat on aldose reductase and aldehyde reductase activity evaluated by a new method using HPLC with post-column spectrophotometric detection

Citation
K. Mizuno et al., Inhibitory effects of fidarestat on aldose reductase and aldehyde reductase activity evaluated by a new method using HPLC with post-column spectrophotometric detection, BIOL PHAR B, 23(2), 2000, pp. 244-248
Citations number
20
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOLOGICAL & PHARMACEUTICAL BULLETIN
ISSN journal
09186158 → ACNP
Volume
23
Issue
2
Year of publication
2000
Pages
244 - 248
Database
ISI
SICI code
0918-6158(200002)23:2<244:IEOFOA>2.0.ZU;2-A
Abstract
A new method to assay the activity of aldose reductase (AR) and aldehyde re ductase (AHR) by high-performance liquid chromatography is described. The s eparation of AR and AHR from tissue extracts using an anion-exchange column was followed by chromatographic measurement of the activity in the elute. AR and AHR activity were expressed as the area under the peak obtained by p ost-column spectrophotometric detection of the decrease of coenzyme (NADPH) in each enzyme reaction. In the enzyme preparation from rat or human tissu es obtained bg this method, two active peaks were identified as AR and AHR, The correlation coefficient between the injection volume of the enzyme pre paration from each tissue and each peak area was 0.998 or greater. In addit ion, the within-day preservation rate of AR or AHR activity from each tissu e was over 95%. In a comparative study of fidarestat with other AR inhibitors using this me thod, it was confirmed that the inhibitory effect of fidarestat on AR activ ity from each rat tissue was more potent than that produced by sorbinil and equipotent to that of epalrestat and zenarestat, Fidarestat was also found to inhibit AR activity more potently than AHR activity in human erythrocyt es. Therefore, this method is applicable to studies of the selective inhibi tion of AR or AHR by test compounds.